Recommendations For Valeant Pharmaceuticals International
Valeant Pharmaceuticals International (VRX.N) (New York Stock Exchange)
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | December | 27 Nov 2009 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 0 | 0 | 0 |
| (2) OUTPERFORM | 0 | 0 | 0 | 0 |
| (3) HOLD | 2 | 3 | 3 | 3 |
| (4) UNDERPERFORM | 3 | 3 | 3 | 3 |
| (5) SELL | 1 | 1 | 2 | 2 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 3.43 | 3.71 | 3.88 | 3.88 |
Market Update
India
US
UK- Asia
- Most Actives
Commodities
| Commodity | Last | Pct Chg | Trade Date/Time |
|---|---|---|---|
| Oil | 77.05 | -1.80% | 11/26 23:59 IST |
| Gold | 1192.8 | +0.49% | 11/26 05:30 IST |
